Abstract:Therapeutic potential of resveratrol on cancer and molecular mechanims based on different preclinical and clinical assessments. Resveratrol is a widely recognized polyphenolic phytochemical found in various plants and their fruits, such as peanuts, grapes, and berry fruits. It is renowned for its several health advantages. The phytochemical is well known for its anticancer properties, and a substantial amount of clinical evidence has also established its promise as a chemotherapeutic agent. This study focuses on assessing the anticancer properties of resveratrol and gaining insight into the underlying molecular mechanisms. It also evaluates the biopharmaceutical, toxicological characteristics, and clinical utilization of resveratrol to determine its suitability for further development as a reliable anticancer agent. Therefore, the information about preclinical and clinical studies was collected from different electronic databases up‐to‐date (2018–2023). Findings from this study revealed that resveratrol has potent therapeutic benefits against various cancers involving different molecular mechanisms, such as induction of oxidative stress, cytotoxicity, inhibition of cell migration and invasion, autophagy, arresting of the S phase of the cell cycle, apoptotic, anti‐angiogenic, and antiproliferative effects by regulating different molecular pathways including PI3K/AKT, p38/MAPK/ERK, NGFR‐AMPK‐mTOR, and so on. However, the compound has poor oral bioavailability due to reduced absorption; this limitation is overcome by applying nanotechnology (nanoformulation of resveratrol). Clinical application also showed therapeutic benefits in several types of cancer with no serious adverse effects. We suggest additional extensive studies to further check the efficacy, safety, and long‐term hazards. This could involve a larger number of clinical samples to establish the compound as a reliable drug in the treatment of cancer.

Resveratrol: an Overview of Its Anti-Cancer Mechanisms

Resveratrol and cancer treatment: updates

The Role of Resveratrol in Cancer Therapy

Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer

Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms

Resveratrol for Cancer Therapy: Challenges and Future Perspectives

Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review

A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives

A Review of Compounds for Prevention of Colorectal Cancer

Resveratrol and its analogues: promising antitumor agents.

Resveratrol and Cervical Cancer: A New Therapeutic Option?

Resveratrol as an anti-cancer agent: A review

Resveratrol, Epigallocatechin Gallate and Curcumin for Cancer Therapy: Challenges from Their Pro-Apoptotic Properties

Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy

Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review

Targeting microbiota-host interactions with resveratrol on cancer: Effects and potential mechanisms of action

Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer

Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment

Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers

A Review on some dietary phytochemicals as potential cancer chemoprevention and chemotherapeutic agents

Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers